Hydroxychloroquine might reduce mortality in patients with systemic sclerosis

International Journal of Rheumatic DiseasesEarly View CORRESPONDENCE Hydroxychloroquine might reduce mortality in patients with systemic sclerosis Eda Otman, Corresponding Author Eda Otman [email protected] orcid.org/0000-0002-9628-4305 Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey Correspondence Eda Otman, Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey. Email: [email protected]Search for more papers by this authorSercan Gucenmez, Sercan Gucenmez orcid.org/0000-0001-7785-4061 Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, TurkeySearch for more papers by this authorDilek Solmaz, Dilek Solmaz orcid.org/0000-0002-9035-689X Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, TurkeySearch for more papers by this authorServet Akar, Servet Akar orcid.org/0000-0002-3734-1242 Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, TurkeySearch for more papers by this authorMustafa Ozmen, Mustafa Ozmen orcid.org/0000-0001-6795-2856 Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, TurkeySearch for more papers by this author Eda Otman, Corresponding Author Eda Otman [email protected] orcid.org/0000-0002-9628-4305 Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey Correspondence Eda Otman, Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey. Email: [email protected]Search for more papers by this authorSercan Gucenmez, Sercan Gucenmez orcid.org/0000-0001-7785-4061 Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, TurkeySearch for more papers by this authorDilek Solmaz, Dilek Solmaz orcid.org/0000-0002-9035-689X Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, TurkeySearch for more papers by this authorServet Akar, Servet Akar orcid.org/0000-0002-3734-1242 Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, TurkeySearch for more papers by this authorMustafa Ozmen, Mustafa Ozmen orcid.org/0000-0001-6795-2856 Division of Rheumatology, Department of Internal Medicine, Ataturk Education and Research Hospital, Izmir Katip Celebi University, Izmir, TurkeySearch for more papers by this author First published: 18 March 2023 https://doi.org/10.1111/1756-185X.14670Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Early ViewOnline Version of Record before inclusion in an issue RelatedInformation